Allogene Therapeutics, Inc. short interest in 2020
In 2020, Allogene Therapeutics, Inc.'s disclosed short interest ran from 10.69% of shares outstanding on 15 Jan 2020 to 9.29% on 31 Dec 2020, a change of -1.40 percentage points. The year's high was 11.58% on 15 Apr 2020 and its low 7.23% on 30 Oct 2020, averaging 9.30% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 32.57 days on 14 Feb 2020. Full history: Allogene Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 10.69% (15 Jan 2020)
- End of year
- 9.29% (31 Dec 2020)
- Change
- -1.40 pp
- High
- 11.58% (15 Apr 2020)
- Low
- 7.23% (30 Oct 2020)
- Average
- 9.30%
- Highest days to cover
- 32.57 (14 Feb 2020)
- SEC filings marked
- 8
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 10.69% | 29.65 | |
| 31 Jan 2020 | 10.54% | 22.69 | |
| 14 Feb 2020 | 10.68% | 32.57 | |
| 28 Feb 2020 | 10.62% | 16.18 | 10-K filed, results (8-K) |
| 13 Mar 2020 | 10.86% | 16.69 | |
| 31 Mar 2020 | 10.83% | 19.87 | |
| 15 Apr 2020 | 11.58% | 22.67 | |
| 30 Apr 2020 | 10.80% | 20.57 | |
| 15 May 2020 | 10.74% | 8.64 | 10-Q filed, results (8-K) |
| 29 May 2020 | 10.57% | 13.28 | |
| 15 Jun 2020 | 9.17% | 6.82 | |
| 30 Jun 2020 | 10.71% | 15.34 | |
| 15 Jul 2020 | 9.62% | 19.54 | |
| 31 Jul 2020 | 8.78% | 27.34 | |
| 14 Aug 2020 | 7.68% | 18.39 | 10-Q filed, results (8-K) |
| 31 Aug 2020 | 7.72% | 21.61 | |
| 15 Sep 2020 | 7.33% | 23.39 | |
| 30 Sep 2020 | 7.44% | 15.55 | |
| 15 Oct 2020 | 7.26% | 19.37 | |
| 30 Oct 2020 | 7.23% | 23.21 | |
| 13 Nov 2020 | 7.55% | 9.77 | 10-Q filed, results (8-K) |
| 30 Nov 2020 | 7.59% | 16.17 | |
| 15 Dec 2020 | 8.03% | 11.34 | |
| 31 Dec 2020 | 9.29% | 14.38 |
See also: Allogene Therapeutics, Inc.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.